Help us Blow Up Lung Cancer!

November is Lung Cancer Awareness Month, and Lexicon is being challenged to Blow it Up for Lung Cancer.

A simple task, such as blowing up a balloon, is next to impossible for lung cancer patients to do. Throughout November, Lexicon employees can purchase a balloon to support Lung Cancer Connection. Lexicon will match employee donations up to $2,000. Employees may purchase a balloon for $1 or 6 balloons for $5. When you make your donation, you are encouraged to share the name of a loved one who has had lung cancer or died from the disease, and their name will be written on a balloon in their honor.

With a mission to raise awareness, increase patient and family support, and advocate for greater funding for lung cancer research, screening, and treatment, Lung Cancer Connection is a non-profit organization comprised of lung cancer patients, survivors, family, friends, and medical professionals, all dedicated to providing information, education, resources, and hope about this devastating disease.

Balloons purchased will be filled and placed in Scott Brennan's office at the end of the month!

Lung Cancer Connection donates all Blow-Up Lung Cancer donations to Dr. Ramaswamy Govindan's lung cancer research at Washington University to enhance patients' treatments.

About Dr. Govindan

Dr. Ramaswamy Govindan is a Professor of Medicine and the Director of the Section of Medical Oncology at Siteman Cancer Center at Washington University in St. Louis. Dr. Govindan is not only a practicing medical oncologist at Siteman Cancer Center, but he also leads a team of Washington University physicians and scientists who are developing new therapies and leading clinical trials that investigate promising new approaches to the disease. Our contributions alone have yielded a nearly 100-fold return in Dr. Govindan's grant funding from the National Cancer Institute (NCI) - which is a true testament to the power of philanthropy in fueling research.

“We no longer stop at the microscopic level when diagnosing cancer,” said Govindan, co-leader of Siteman Cancer Center’s solid tumor program and a leader in lung cancer clinical trials and translational research. “Now we do molecular profiling and study the genes that are altered to see whether we can use targeted therapies.” Depending on the situation, that might involve using a targeted chemotherapy or customized tumor vaccine, either as part of a clinical trial or as a standard of care.

Dr. Govindan’s group is trying to understand the reasons why cancer cells metastasize or become unresponsive to medical therapies. He also is using sequencing to develop a neoantigen vaccine that he is testing in a trial for patients with non-small cell lung cancer, the most common form of the disease.”

Lexicon - Blow Up Lung Cancer 2020

By Lung Cancer Connection

Lexicon - Blow Up Lung Cancer 2020

Purchase balloons to help fund lung cancer research and help Blow Up Lung Cancer!